Network Pharmacology Analysis of ZiShenWan for Diabetic Nephropathy and Experimental Verification of Its Anti-Inflammatory Mechanism

BACKGROUND: Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD). The inflammatory response plays a critical role in DN. ZiShenWan (ZSW) is a classical Chinese medicinal formula with remarkable clinical therapeutic effects on DN, but its pharmacological action mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xiaoyuan, Wu, You, Zhang, Chengfei, Wu, Lili, Qin, Lingling, Liu, Tonghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055297/
https://www.ncbi.nlm.nih.gov/pubmed/33883881
http://dx.doi.org/10.2147/DDDT.S297683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055297/
https://www.ncbi.nlm.nih.gov/pubmed/33883881
http://dx.doi.org/10.2147/DDDT.S297683

Ejemplares similares